» Articles » PMID: 12460888

Multiple Genes in Human 20q13 Chromosomal Region Are Involved in an Advanced Prostate Cancer Xenograft

Overview
Journal Cancer Res
Specialty Oncology
Date 2002 Dec 4
PMID 12460888
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed a prostate cancer xenograft derived from a locally advanced tumor using combined cytogenetic, array-based comparative genomic hybridization and expression analyses. This analysis revealed that genes in the 20q13 chromosomal region, CSE1L, ZNF217, MYBL2, and STK15, were significantly overexpressed in this tumor. The expression pattern of these genes was then confirmed in two large human prostate cancer microarray databases. Furthermore, the MYBL2 and STK15 have been significantly overexpressed in prostate metastases, allowing a clear distinction between localized tumors and metastases. Our data suggest these genes to be involved in advanced stages of prostate tumorigenesis and as such, they may serve as markers for tumor progression.

Citing Articles

MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer.

German B, Alaiwi S, Ho K, Nanda J, Fonseca M, Burkhart D Cancer Res Commun. 2024; 4(9):2295-2307.

PMID: 39113611 PMC: 11368174. DOI: 10.1158/2767-9764.CRC-24-0069.


Increased copy number of imprinted genes in the chromosomal region 20q11-q13.32 is associated with resistance to antitumor agents in cancer cell lines.

Krushkal J, Vural S, Jensen T, Wright G, Zhao Y Clin Epigenetics. 2022; 14(1):161.

PMID: 36461044 PMC: 9716673. DOI: 10.1186/s13148-022-01368-7.


Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma.

Huang C, Han W, Wu Y, Shen G Front Genet. 2022; 13:817656.

PMID: 35991567 PMC: 9387026. DOI: 10.3389/fgene.2022.817656.


MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad/SNAI1 pathway.

Wei M, Yang R, Ye M, Zhan Y, Liu B, Meng L Am J Cancer Res. 2022; 12(5):1960-1981.

PMID: 35693071 PMC: 9185624.


Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma.

Liu J, Xu J, Luo B, Tang J, Hou Z, Zhu Z Cancers (Basel). 2022; 14(6).

PMID: 35326741 PMC: 8946480. DOI: 10.3390/cancers14061590.